The global high-performance liquid chromatography (HPLC) market is estimated to have a CAGR of around 5% during the forecast period. The growing R&D and clinical research further encourage HPLC demand that further contribute to the market growth. Recent advancement such as microarray-based expression profiling in genomics, proteomics, and drug discovery domains, created new possibilities for the diagnosis and treatment of various fatal diseases such as cancer and CVD.
Browse
the full report description Global (High-Performance Liquid Chromatography)
HPLC Market Size, Share & Trends Analysis Report by Product Type
(Consumables, Instruments, and Accessories), Application (Virtualized
Application and Centralized Application), and Forecast 2019-2025 at
HPLC supported R&D programs and other research studies to discover and develop safe and effective drugs for various chronic diseases including Cancer, Diabetes, and neurological diseases, among others. Research programs related to human genetics have been analyzed in combination with health data and have become increasingly vital for understanding the most complex diseases.
Government grants and funding are expected to boost the research programs for the prevention, diagnosis, treatment, intervention, and discovery of new drugs. The increase in R&D expenditure is also driven by increasing pharmaceutical sales coupled with technological advancement. A significant increase in government funding for R&D programs has boosted the drug discovery industry and other associated markets such as biological sample handling.
In 2018, it was stated by the NIH (National Institutes of Health), one of the foremost medical research centers, globally, that it invests around $39 billion for medical research in the US annually. Over 80% of the organization’s funding is granted through around 50,000 competitive grants to over 300,000 researchers at research institutions, medical schools, and universities across the US and other economies.
The development of informatics and analytical technologies is contributing to the growth of the HPLC market. Recent advances in metabolomics analytical technologies disclose the explicit value of metabolomics tools in gene-function analysis, diagnostic platforms, biomarker discovery, and systems biology. Since metabolites characterize the downstream appearance of proteome, genome, and transcriptome, these can thoroughly imitate the phenotype of an organism at an explicit period. The development in mass spectrometry coupled with chromatography has advanced the reliability and efficiency of metabolomic profiling and shows the key structures in medical fields.
Growing product offering by market players boost the High-Performance Liquid Chromatography (HPLC) market growth
Various companies are offering HPLC systems such as PerkinElmer Inc., Agilent Technologies, Inc., GE Healthcare and so on. ÄKTA chromatography systems and UNICORN control software are offered by GE life science for analysis of biochemical activity during drug discovery and toxicology study. An automated liquid chromatography system, ÄKTAprocess is used for scale-up and large-scale biopharmaceutical manufacturing processes. The system is available in three flow rate ranges that extend up to 2000 L/h for large volume manufacturing.
Further, Thermo Scientific offer HPLC products that provide larger retention, flexible lab integration with minimal maintenance, and time stability for all liquid chromatography applications. Rapid Separation (RS) HPLC Systems are offered by Thermo scientific with the ability to use small particle columns for fast separations. Therefore, these advanced technologies offering by the HPLC further propel the market growth.
Global HPLC Market Segmentation
By Product Type
By Application
Global HPLC Market – Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To
learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/hplc-market